|
|
||||||||



Departments of
*
Microbiology and Immunology and
Medicine, Division of Infectious Diseases, Thomas Jefferson University, Philadelphia, PA 19107;
The Histocompatibility Laboratory, American Red Cross, Philadelphia, PA 19123;
§
Department of Microbiology and Immunology, Nippon Medical School, Tokyo, Japan;
¶
Department of Immunology, Juntendo University School of Medicine, Tokyo, Japan; and
||
Ajinomoto Co., Inc., Kyobashi, Tokyo, Japan
New strategies for improving the efficacy of HIV vaccines are of
significant importance. In this study, we analyzed the effect of
deletion of the hypervariable V3 loop of gp120 on envelope
(env)-specific CTL responses in PBMC of HIV-infected individuals. We
showed increased CTL activities against conserved epitopes of the env
glycoprotein in cultures induced with the
V3 mutant compared with
those stimulated with the full-length env gene products. In contrast to
the wild-type env, the
V3 mutant-expressing cells were resistant to
Ab-dependent cell-mediated cytotoxicity, formed no syncytia, and
neither underwent nor induced apoptosis in CD4+
cells. Thus, the
V3 mutant may redirect immune responses toward
conserved epitopes of gp160, has longer expression time due to
increased resistance to Ab-dependent cell-mediated cytotoxicity, and
does not trigger cytopathic effects associated with apoptosis and
syncytium formation. This approach may apply to other Ags of HIV, where
deletions of highly variable or immunosuppressive epitopes may improve
the efficacy of HIV vaccines.
This article has been cited by other articles:
![]() |
E. Bolesta, A. Kowalczyk, A. Wierzbicki, C. Eppolito, Y. Kaneko, M. Takiguchi, L. Stamatatos, P. A. Shrikant, and D. Kozbor Increased Level and Longevity of Protective Immune Responses Induced by DNA Vaccine Expressing the HIV-1 Env Glycoprotein when Combined with IL-21 and IL-15 Gene Delivery J. Immunol., July 1, 2006; 177(1): 177 - 191. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Kiszka, D. Kmieciak, J. Gzyl, T. Naito, E. Bolesta, A. Sieron, S. P. Singh, A. Srinivasan, G. Trinchieri, Y. Kaneko, et al. Effect of the V3 Loop Deletion of Envelope Glycoprotein on Cellular Responses and Protection against Challenge with Recombinant Vaccinia Virus Expressing gp160 of Primary Human Immunodeficiency Virus Type 1 Isolates J. Virol., March 27, 2002; 76(9): 4222 - 4232. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |